Nanoparticles enhance gene therapies for eye disease
NIBIB-funded researchers have created nanoparticles for successful gene therapy in a mouse model of macular degeneration. The nanoparticle carriers have the potential to significantly expand the effectiveness of gene therapies for human eye diseases, including blindness.
No hay comentarios:
Publicar un comentario